Scientists developed a new vaccine platform that is faster, cheaper, and easier to distribute than current methods. Using ...
Elegen sets a new benchmark for clonal, cell-free synthetic DNA with ENFINIA, delivering unmatched length and accuracy from ...
In this second of three articles on The Sunday Times top 100 tech companies list, pharmaphorum is focusing on the first nine ...
Thermo Fisher Scientific Inc. TMO is slated to release fourth-quarter 2025 results on Jan. 29, before market open. In the last reported quarter, earnings of $5.79 per share beat the Zacks Consensus ...
The problem of antibiotic-resistant bacteria has many health experts worried. As disease-causing bacteria adapt to some of ...
Elegen today announced significant price reductions across its ENFINIAtm DNA portfolio, now offering high-accuracy, clonal, cell-free synthetic DNA with list pricing as low as $0.07 per base pair.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results